Mylotarg and alanine aminotransferase increased 
Mylotarg and alanine aminotransferase increased Patient Reports February 09, 2010
Mylotarg Side Effects Report #5090629-2
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 11, 2006. Male patient, 39 years of age, weighting 132.9 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood creatinine increased, blood culture positive, enterococcal infection, febrile neutropenia, gastrointestinal haemorrhage. Mylotarg dosage: 15 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with KALETRA, EPIVIR, ABACAVIR, SYNTHROID, PROTONIX, AMOXICILLIN, ALLOPURINOL, AMPICILLIN. Patient was hospitalized. Patient died on 12/03/2002.
Mylotarg Side Effects Report #5148813-5
Mylotarg side effect was reported by a Health Professional from UNITED STATES on Oct 31, 2006. Male patient, 39 years of age, weighting 132.9 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood creatinine increased, enterococcal infection, febrile neutropenia, gastrointestinal haemorrhage, hypotension, leukocytosis. Mylotarg dosage: 15 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with KALETRA, EPIVIR, ABACAVIR, SYNTHROID, PROTONIX, AMOXICILLIN, ALLOPURINOL, AMPICILLIN. Patient was hospitalized. Patient died on 12/03/2002.
Mylotarg Side Effects Report #4774007-9
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 07, 2005. Male patient, 70 years of age, was diagnosed with myelodysplastic syndrome and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood alkaline phosphatase increased, blood creatine increased, chest x-ray abnormal, dyspnoea, haemoglobin decreased, haemorrhage. Mylotarg dosage: 7 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with ARSENIC TRIOXIDE, PRINIVIL, VITAMINS, TRICOR. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5353522-3
Mylotarg side effect was reported by a Pharmacist from UNITED STATES on June 08, 2007. Male patient, 67 years of age, weighting 234.0 lb, was diagnosed with leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal pain
, alanine aminotransferase increased, ascites, asthenia, blood bilirubin increased, fatigue, hypotension, neutropenia, portal vein thrombosis. Mylotarg dosage: 20MG EA. DOSE -14-DAYS APART- Q14 DAYS IV. Patient died on 09/01/2006.Mylotarg Side Effects Report #5059006-4
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 10, 2006. Female patient, 63 years of age, weighting 108.0 lb, was diagnosed with chronic myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal tenderness, activated partial thromboplastin time prolonged, alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood bilirubin increased. Mylotarg dosage: 13 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, GEMCITABINE, NOVANTRONE, DIFLUCAN, DILAUDID, ATIVAN, LEVAQUIN, INSULIN. Patient was hospitalized. Patient died on 04/02/2003.
Mylotarg Side Effects Report #5119013-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 22, 2006. Male patient, 55 years of age, weighting 280.3 lb, was diagnosed with acute promyelocytic leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, biopsy bone marrow abnormal, chills, enterococcal bacteraemia, febrile neutropenia, heparin-induced thrombocytopenia, weight increased. Mylotarg dosage: unknown. During the same period patient was treated with ACYCLOVIR, GENTAMICIN SULPHATE, ALLOPURINOL, COLACE, DIFLUCAN, PROTONIX, VITAMIN B. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5123334-4
Mylotarg side effect was reported by a Health Professional from JAPAN on Sept 25, 2006. Female patient, 78 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, conjunctival haemorrhage, febrile neutropenia, haematuria, hepatomegaly. Mylotarg dosage: unknown. During the same period patient was treated with AMLODIPINE BESYLATE, LOSARTAN POTASSIUM, SULFAMETHOXAZOLE, FLUCONAZOLE, FAMOTIDINE, MUCOSTA, POLYMYXIN B SULPHATE. Patient recovered.
Mylotarg Side Effects Report #4937095-2
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Feb 17, 2006. Male patient, 78 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, anorexia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, bone marrow failure, condition aggravated, febrile neutropenia. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with MODACIN, SULPERAZON, TIENAM, CIPROFLOXACIN HYDROCHLORIDE, MEROPEN, PRODIF, POLYMYXIN B SULPHATE. Patient recovered.
Mylotarg Side Effects Report #5206008-0
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Oct 27, 2006. Male patient, 73 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood chloride decreased, blood creatinine increased, blood lactate dehydrogenase increased, blood potassium increased, blood sodium decreased. Mylotarg dosage: 9 MG/M2 1X PER 1 DAY; INTRAVENOUS DRIP. Patient was hospitalized. Patient died.
Mylotarg Side Effects Report #4929638-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 09, 2006. Female patient, 73 years of age, weighting 140.9 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, disease progression, febrile neutropenia, hepatic enzyme increased. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE, INTRAVENOUS. Patient was hospitalized. Patient died on 09/05/2005.
Mylotarg Side Effects Report #5196079-2
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Dec 07, 2006. Female patient, 72 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, blood bilirubin increased, disseminated intravascular coagulation, lymphocyte percentage decreased, lymphocyte percentage increased, neutrophil percentage decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with FAMOTIDINE, ASPARA K, ITRACONAZOLE, SULFAMETHOXAZOLE, BIOFERMIN. Patient died.
Mylotarg Side Effects Report #5201931-5
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Dec 26, 2006. Female patient, 70 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, gastroenteritis staphylococcal, malaise, neutrophil count decreased, platelet count decreased, pneumonia
. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with NEUPOGEN, ITRACONAZOLE, ALLOPURINOL, DIOVAN, INSULIN, EXACIN. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5217083-1
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Jan 11, 2007. Male patient, 70 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, blood alkaline phosphatase increased, blood pressure increased, c-reactive protein increased, fibrin degradation products increased, hepatic function abnormal, nausea
, neutrophil count decreased. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE; SEE IMAGE. During the same period patient was treated with TSUKUSHI AM, ISODINE, POLYMYXIN B SULPHATE, ITRACONAZOLE, FAMOTIDINE, NITRAZEPAM, SOLITA T. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5124757-X
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Sept 27, 2006. Female patient, 70 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, gastroenteritis staphylococcal, malaise, neutrophil count decreased, platelet count decreased, pneumonia
, pneumonia cytomegaloviral. Mylotarg dosage: unknown. During the same period patient was treated with NEUPOGEN, ITRACONAZOLE, ALLOPURINOL, DIOVAN, INSULIN, EXACIN. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5050786-0
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on June 27, 2006. Female patient, 69 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time shortened, alanine aminotransferase increased, aspartate aminotransferase increased, blood calcium decreased, blood creatinine decreased, blood creatinine increased, blood lactate dehydrogenase increased, blood potassium decreased, blood sodium decreased. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE. During the same period patient was treated with CEFTAZIDIME, ANTITHROMBIN III, NORMAL IMMUNOGLOBULIN, AMIKACIN SULPHATE, AMIKACIN SULPHATE, MEROPEN. Patient died.
Mylotarg Side Effects Report #5043092-1
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on June 15, 2006. Male patient, 66 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, blood lactate dehydrogenase increased, disseminated intravascular coagulation, hepatic function abnormal, infection
, interstitial lung disease. Mylotarg dosage: 9 MG/M^2 1 PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with POLYMYXIN B SULPHATE, RABEPRAZOLE, NEUTROGIN. Patient died.Mylotarg Side Effects Report #4942761-9
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Mar 01, 2006. Male patient, 65 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, diarrhoea, haemoglobin decreased, herpes zoster, hypokalaemia, malignant neoplasm progression. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with CIPROFLOXACIN HYDROCHLORIDE, SULFAMETHOXAZOLE, TIENAM. Patient died.
Mylotarg Side Effects Report #4991409-6
Mylotarg side effect was reported by a Physician from JAPAN on Apr 25, 2006. Male patient, 65 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, bacterial infection
, blood alkaline phosphatase increased, blood pressure decreased, depressed level of consciousness, diarrhoea. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with CIPROFLOXACIN HYDROCHLORIDE, SULFAMETHOXAZOLE, TIENAM, MAXIPIME. Patient died.Mylotarg Side Effects Report #5202114-5
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Dec 25, 2006. Male patient, 63 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood bilirubin increased, blood creatinine increased, blood lactate dehydrogenase increased, blood potassium decreased, blood urea increased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, DAUNORUBICIN HYDROCHLORIDE, LEVOFLOXACIN, DIFLUCAN, ETOPOSIDE, SULPERAZON. Patient was hospitalized and became disabled. Patient recovered.
Mylotarg Side Effects Report #5110872-3
Mylotarg side effect was reported by a Health Professional from JAPAN on Sept 06, 2006. Male patient, 63 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood bilirubin increased, blood creatinine increased, blood lactate dehydrogenase increased, blood potassium decreased, blood pressure decreased, blood urea increased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, DAUNORUBICIN HYDROCHLORIDE, CRAVIT, DIFLUCAN, ETOPOSIDE, SULPERAZON. Patient was hospitalized. Patient died.
Mylotarg Side Effects Report #5158276-1
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Nov 10, 2006. Male patient, 63 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood bilirubin increased, blood creatinine increased, blood lactate dehydrogenase increased, blood potassium decreased, blood urea increased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, DAUNORUBICIN HYDROCHLORIDE, LEVOFLOXACIN, DIFLUCAN, ETOPOSIDE, SULPERAZON. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4992456-0
Mylotarg side effect was reported by a Health Professional from JAPAN on Apr 19, 2006. Male patient, 63 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, infection
, liver disorder, multi-organ failure, renal disorder. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE, INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, ACLACINON. Patient died.Mylotarg Side Effects Report #5223781-6
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Jan 18, 2007. Male patient, 61 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bronchopulmonary aspergillosis, cardio-respiratory arrest, hepatic function abnormal, white blood cell count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with ITRACONAZOLE, LEVOFLOXACIN, FAMOTIDINE, BACTRIM. Patient died.
Mylotarg Side Effects Report #5220632-0
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Jan 11, 2007. Male patient, 56 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, depression
, haematocrit decreased, haemoglobin decreased, hepatic function abnormal, insomnia, intraocular pressure increased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with INSULIN, POLYMYXIN B SULPHATE, ITRACONAZOLE, FAMOTIDINE, MUCOSTA, PREDNISOLONE, SULFAMETHOXAZOLE. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5104160-9
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Aug 29, 2006. Male patient, 56 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood pressure decreased, body temperature decreased, disseminated intravascular coagulation, gamma-glutamyltransferase increased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP; 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with OMEPRAZOLE, MAXIPIME, AMIKACIN SULPHATE, MEROPENEM, TIENAM, CIPROXAN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4839607-6
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Nov 10, 2005. Female patient, 44 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, chills, disseminated intravascular coagulation, febrile neutropenia, fibrin degradation products increased, gamma-glutamyltransferase increased. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE, INTRAVENOUS DRIP. During the same period patient was treated with LAMIVUDINE, COTRIM, DIFLUCAN, CIPROFLOXACIN HYDROCHLORIDE, ZOLPIDEM TARTRATE, MAXIPIME. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4867132-5
Mylotarg side effect was reported by a Physician from JAPAN on Dec 13, 2005. Female patient, 44 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, bone marrow failure, c-reactive protein increased, disseminated intravascular coagulation, febrile neutropenia, fibrin degradation products increased. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with LAMIVUDINE, COTRIM, DIFLUCAN, CIPROFLOXACIN HYDROCHLORIDE, ZOLPIDEM TARTRATE, MAXIPIME. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4906948-3
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Jan 26, 2006. Female patient, 44 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, c-reactive protein increased, chills, febrile neutropenia, fibrin degradation products increased, gamma-glutamyltransferase increased. Mylotarg dosage: A SINGLE 9MG/M2 DOSE. During the same period patient was treated with LAMIVUDINE, SULFAMETHOXAZOLE, DIFLUCAN, CIPROFLOXACIN HYDROCHLORIDE, ZOLPIDEM TARTRATE, MAXIPIME. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4917046-7
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Feb 02, 2006. Female patient, 44 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, blood stem cell transplant failure, bone marrow failure, c-reactive protein increased, disease progression. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with LAMIVUDINE, SULFAMETHOXAZOLE, DIFLUCAN, CIPROFLOXACIN HYDROCHLORIDE, ZOLPIDEM TARTRATE, MAXIPIME. Patient was hospitalized. Patient died.
Mylotarg Side Effects Report #5080715-5
Mylotarg side effect was reported by a Health Professional from JAPAN on July 28, 2006. Male patient, 23 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, febrile neutropenia, liver disorder, lymphadenitis, nausea
, neutrophil count decreased. Mylotarg dosage: A SINGEL 9 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with SELBEX, GASMOTIN, TOSUFLOXACIN TOSILATE, DIFLUCAN, FIRSTCIN, MEROPEN, TARGOCID, PAZUCROSS. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5235843-8
Mylotarg side effect was reported by a Physician from JAPAN on Jan 31, 2007. Male patient, weighting 114.6 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, disease progression, disseminated intravascular coagulation, dyspnoea, fall
. Mylotarg dosage: unknown. During the same period patient was treated with LENDORMIN, ARTIST, TAKEPRON, MUCOSTA. Patient recovered.Mylotarg Side Effects Report #5294652-4
Mylotarg side effect was reported by a Physician from JAPAN on Apr 03, 2007. Male patient, weighting 119.0 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, pneumonia
. Mylotarg dosage: unknown. During the same period patient was treated with GASTER, DIFLUCAN, LEVOFLOXACIN, LASIX, SELBEX. Patient died on 03/27/2007.Mylotarg Side Effects Report #5315496-0
Mylotarg side effect was reported by a Physician from JAPAN on Apr 24, 2007. Male patient, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, blood urea increased, chills. Mylotarg dosage: unknown. During the same period patient was treated with HYDROCORTISONE SUCCINATE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5376161-7
Mylotarg side effect was reported by a Physician from JAPAN on June 27, 2007. Male patient, weighting 116.8 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood chloride decreased, blood creatinine increased, blood lactate dehydrogenase increased, blood potassium increased, blood sodium decreased. Mylotarg dosage: unknown. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5410045-0
Mylotarg side effect was reported by a Physician from JAPAN on Aug 01, 2007. Female patient, weighting 138.9 lb, was diagnosed with acute myeloid leukaemia recurrent, interstitial lung disease, gingivitis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, body temperature decreased, gingivitis, interstitial lung disease, liver disorder, pyrexia, toxic skin eruption. Mylotarg dosage: unknown. During the same period patient was treated with PREDNISOLONE, AMINOACETIC ACID, DALACIN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5420780-6
Mylotarg side effect was reported by a Physician from JAPAN on Aug 17, 2007. Male patient, weighting 116.8 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood chloride decreased, blood creatinine increased, blood lactate dehydrogenase increased, blood potassium increased, blood sodium decreased. Mylotarg dosage: unknown. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5511142-1
Mylotarg side effect was reported by a Physician from JAPAN on Oct 30, 2007. Male patient, weighting 123.5 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, blood pressure diastolic increased, disease progression, gamma-glutamyltransferase increased. Mylotarg dosage: unknown. During the same period patient was treated with BAKTAR, OMEPRAZOLE, PROGRAF, UNIPHYL, BEZATOL, PREDONINE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5645621-3
Mylotarg side effect was reported by a Physician from JAPAN on Feb 18, 2008. Male patient, weighting 116.8 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood cholinesterase decreased, blood lactate dehydrogenase increased, blood potassium decreased. Mylotarg dosage: unknown. During the same period patient was treated with PREDNISOLONE, PARIET, BAKTAR, METHOTREXATE, DIFLUCAN, CIPROFLOXACIN, GLYSENNID. Patient was hospitalized and became disabled. Patient recovered.
Mylotarg Side Effects Report #5674263-9
Mylotarg side effect was reported by a Physician from JAPAN on Mar 13, 2008. Male patient, weighting 198.4 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, pneumonia fungal. Mylotarg dosage: unknown. During the same period patient was treated with FAMOTIDINE, ITRACONAZOLE. Patient died on 03/27/2007.
Mylotarg Side Effects Report #5797024-9
Mylotarg side effect was reported by a Physician from JAPAN on June 23, 2008. Male patient, weighting 116.8 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood cholinesterase decreased, blood lactate dehydrogenase increased, blood potassium decreased. Mylotarg dosage: unknown. During the same period patient was treated with PREDNISOLONE, RABEPRAZOLE, BAKTAR, METHOTREXATE, DIFLUCAN, CIPROFLOXACIN, GLYSENNID. Patient was hospitalized and became disabled. Patient recovered.
Mylotarg Side Effects Report #5822128-1
Mylotarg side effect was reported by a Physician from JAPAN on July 16, 2008. Male patient, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatomegaly, hypoalbuminaemia. Mylotarg dosage: unknown. During the same period patient was treated with HYDROCORTISONE SUCCINATE. Patient was hospitalized. Patient died on 12/09/2007.
Mylotarg Side Effects Report #5863189-3
Mylotarg side effect was reported by a Physician from JAPAN on Aug 19, 2008. Male patient, weighting 116.8 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood cholinesterase decreased, blood lactate dehydrogenase increased, blood potassium decreased. Mylotarg dosage: unknown. During the same period patient was treated with PREDNISOLONE, RABEPRAZOLE, COTRIM, METHOTREXATE, DIFLUCAN, CIPROFLOXACIN, PURSENNID. Patient was hospitalized and became disabled. Patient recovered.
Mylotarg Side Effects Report #5971499-4
Mylotarg side effect was reported by a Physician from JAPAN on Nov 19, 2008. Male patient, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatomegaly, hypoalbuminaemia. Mylotarg dosage: unknown. During the same period patient was treated with HYDROCORTISONE SUCCINATE. Patient was hospitalized. Patient died on 12/09/2007.
Mylotarg Side Effects Report #6054475-5
Mylotarg side effect was reported by a Physician from JAPAN on Jan 21, 2009. Male patient, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatomegaly, hypoalbuminaemia. Mylotarg dosage: unknown. During the same period patient was treated with HYDROCORTISONE SUCCINATE. Patient was hospitalized. Patient died on 12/09/2007.
Mylotarg Side Effects Report #4955671-8
Mylotarg side effect was reported by a Health Professional from JAPAN on Mar 10, 2006. Female patient, 85 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood creatinine increased, blood urea increased, febrile neutropenia, liver disorder, malignant neoplasm progression. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with ACLARUBICIN HYDROCHLORIDE, FOSMICIN S, MAXIPIME, VANCOMYCIN, FUNGUARD, PAZUCROSS. Patient recovered.
Mylotarg Side Effects Report #5007450-3
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on May 09, 2006. Female patient, 85 years of age, was diagnosed with acute myeloid leukaemia, sepsis
and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, blood urea increased, disease progression. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with CARBENIN, CIPROFLOXACIN, FOSMICIN S, FOSMICIN S, FUNGUARD, MAXIPIME. Patient recovered.Mylotarg Side Effects Report #4676847-3
Mylotarg side effect was reported by a Consumer or non-health professional from on May 18, 2005. Female patient, 82 years of age, weighting 209.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, chills, hyperbilirubinaemia, hypoxia, pyrexia. Mylotarg dosage: 13.16 MG X 1 DOSE, INTRAVENOUS. During the same period patient was treated with CYTARABINE. Patient recovered.
Mylotarg Side Effects Report #4685737-1
Mylotarg side effect was reported by a Consumer or non-health professional from on May 25, 2005. Male patient, 82 years of age, weighting 209.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, chills, hyperbilirubinaemia, hypoxia, pyrexia. Mylotarg dosage: 13.16 MG X 1 DOSE, INTRAVENOUS. During the same period patient was treated with CYTARABINE. Patient recovered.
Mylotarg Side Effects Report #4698708-6
Mylotarg side effect was reported by a Consumer or non-health professional from on June 09, 2005. Male patient, 82 years of age, weighting 209.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, chills, hyperbilirubinaemia, hyperhidrosis, hypoxia, pyrexia. Mylotarg dosage: 13.16 MG X 1 DOSE, INTRAVENOUS. During the same period patient was treated with CYTARABINE. Patient recovered.
Mylotarg Side Effects Report #4947100-5
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 82 years of age, weighting 209.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, chills, hyperbilirubinaemia, hyperhidrosis, hypoxia, infusion related reaction, pyrexia. Mylotarg dosage: 13.16 MG X 1 DOSE; INTRAVENOUS. During the same period patient was treated with CYTARABINE. Patient recovered.
Mylotarg Side Effects Report #5074408-8
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on July 26, 2006. Male patient, 78 years of age, was diagnosed with acute myeloid leukaemia, disease recurrence and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, anorexia, aspartate aminotransferase increased, blood lactate dehydrogenase increased, condition aggravated, disease progression, febrile neutropenia, hypertension. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with CEFTAZIDIME, SULPERAZON, POLYMYXIN B SULPHATE, ULCERMIN, ALLOPURINOL, DIFLUCAN. Patient recovered.
Mylotarg Side Effects Report #5025982-9
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on May 30, 2006. Male patient, 78 years of age, was diagnosed with acute myeloid leukaemia, disease recurrence and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, anaemia, anorexia, aspartate aminotransferase increased, blood lactate dehydrogenase increased, bone marrow failure, condition aggravated, disease progression. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with CEFTAZIDIME, SULPERAZON, POLYMYXIN B SULPHATE, ULCERMIN. Patient recovered.
Mylotarg Side Effects Report #5105261-1
Mylotarg side effect was reported by a Health Professional from UNITED STATES on Aug 28, 2006. Female patient, 77 years of age, weighting 136.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, apparent life threatening event, aspartate aminotransferase increased, bacterial infection
, blood alkaline phosphatase increased, blood bilirubin increased, bronchoalveolar lavage abnormal, culture positive, haemoptysis. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with ELSPAR, CYTARABINE, NOVANTRONE. Patient was hospitalized. Patient died on 02/06/2006.Mylotarg Side Effects Report #4870092-4
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 13, 2002. Female patient, 77 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, disease progression, platelet count decreased, pneumonia fungal. Mylotarg dosage: 8.297 MG 1X PER 1 DAY, INTRAVENOUS; 5.53 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CYTARABINE, ACYCLOVIR, PERIDEX, PREVACID, FLUCONAZOLE, GENTAMICIN, LEVOFLOXACIN. Patient died on 09/05/2002.
Mylotarg Side Effects Report #4944146-8
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 28, 2006. Female patient, 77 years of age, weighting 136.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bacterial infection
, blood alkaline phosphatase increased, blood culture positive, haemoptysis, liver function test abnormal, neutropenia, pneumonia fungal. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with ELSPAR, CYTARABINE, NOVANTRONE. Patient was hospitalized. Patient died on 02/06/2006.Mylotarg Side Effects Report #4969295-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 23, 2006. Female patient, 77 years of age, weighting 136.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bacterial infection
, blood alkaline phosphatase increased, blood bilirubin increased, haemoptysis, neutrophil count decreased, pneumonia fungal, pyrexia. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with ELSPAR, CYTARABINE, NOVANTRONE. Patient was hospitalized. Patient died on 02/06/2006.Mylotarg Side Effects Report #5147197-6
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Nov 02, 2006. Female patient, 76 years of age, was diagnosed with acute myeloid leukaemia, pneumonia
, neutrophil count decreased and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood urea increased, haematocrit decreased, haemoglobin decreased, hypernatraemia, liver disorder, neutrophil count decreased, platelet count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with CIPROXAN, NEUPOGEN, OMEGACIN, VANCOMYCIN, STRONG NEO MINOPHAGEN C, VFEND. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5105036-3
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 29, 2006. Male patient, 75 years of age, weighting 181.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood glucose increased, blood potassium decreased. Mylotarg dosage: unknown. During the same period patient was treated with SERTRALINE, FUROSEMIDE, FAMOTIDINE, METOCLOPRAMIDE, ITRACONAZOLE, CIPROFLOXACIN, ACYCLOVIR. Patient recovered.
Mylotarg Side Effects Report #4627228-X
Mylotarg side effect was reported by a Consumer or non-health professional from on Mar 22, 2005. Male patient, 75 years of age, weighting 181.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood glucose increased, blood potassium decreased. Mylotarg dosage: unknown. During the same period patient was treated with SERTRALINE, FUROSEMIDE, FAMOTIDINE, METOCLOPRAMIDE, ITRACONAZOLE, CIPROFLOXACIN, ACYCLOVIR, IMIPENEM. Patient recovered.
Mylotarg Side Effects Report #4627579-9
Mylotarg side effect was reported by a Consumer or non-health professional from on Mar 22, 2005. Male patient, 75 years of age, weighting 178.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, chest pain
, hypotension. Mylotarg dosage: unknown. During the same period patient was treated with SERTRALINE, CAPTOPRIL, DOCUSATE, FUROSEMIDE. Patient recovered.Mylotarg Side Effects Report #4627583-0
Mylotarg side effect was reported by a Consumer or non-health professional from on Mar 22, 2005. Male patient, 75 years of age, weighting 178.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, chest pain
, hypotension. Mylotarg dosage: unknown. During the same period patient was treated with SERTRALINE, CAPTOPRIL, DOCUSATE, FUROSEMIDE. Patient recovered.Mylotarg Side Effects Report #4663708-9
Mylotarg side effect was reported by a Consumer or non-health professional from on May 03, 2005. Male patient, 75 years of age, weighting 181.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood glucose increased, blood potassium decreased, blood potassium increased. Mylotarg dosage: unknown. During the same period patient was treated with SERTRALINE, FUROSEMIDE, FAMOTIDINE, METOCLOPRAMIDE, ITRACONAZOLE, CIPROFLOXACIN, ACYCLOVIR. Patient recovered.
Mylotarg Side Effects Report #4780622-9
Mylotarg side effect was reported by a Physician from UNITED STATES on Sept 12, 2005. Female patient, 75 years of age, weighting 191.2 lb, was diagnosed with acute myeloid leukaemia, leukaemia recurrent, herpes virus infection and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, cardiomegaly, chest pain
, chills, haematocrit decreased, haemoglobin decreased, herpes virus infection. Mylotarg dosage: 16 MG 1X PER 1 DAY, INTRAVENOUS; 16 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with ACYCLOVIR. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #4949973-9
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 75 years of age, weighting 153.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bacteria stool identified, bilirubin conjugated increased, dehydration, gamma-glutamyltransferase increased, hypotension, infusion related reaction, lung infiltration. Mylotarg dosage: 15 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5091413-6
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 18, 2006. Male patient, 74 years of age, weighting 137.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myocardial infarction, alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, chills, disease progression, hypotension, infusion related reaction. Mylotarg dosage: unknown. Patient was hospitalized. Patient died on 04/16/2005.
Mylotarg Side Effects Report #5062296-5
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 12, 2006. Male patient, 73 years of age, weighting 192.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, blood chloride decreased, haematocrit decreased, haemoglobin decreased, nausea
, platelet count decreased, red blood cell count decreased. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with LEVAQUIN, PROTONIX, DIOVAN, ACYLOVIR, REGLAN, DIFLUCAN, CELEXA, ATIVAN. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #4967135-6
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 21, 2006. Male patient, 73 years of age, weighting 192.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bacterial infection
, blood chloride decreased, haematocrit decreased, haemoglobin decreased, nausea , platelet count decreased, red blood cell count decreased. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with LEVAQUIN, PROTONIX, DIOVAN, ACYCLOVIR, REGLAN, DIFLUCAN, CELEXA, ATIVAN. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5005804-2
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on May 04, 2006. Male patient, 73 years of age, weighting 192.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood chloride decreased, gram stain positive, haematocrit decreased, haemoglobin decreased, nausea
, platelet count decreased, red blood cell count decreased. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with LEVAQUIN, PROTONIX, DIOVAN, ACYCLOVIR, REGLAN, DIFLUCAN, CELEXA, ATIVAN. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #4952650-1
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on June 17, 2004. Female patient, 72 years of age, weighting 121.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, atrial flutter, blood alkaline phosphatase increased, blood urea increased, bradycardia, chills, diarrhoea, dizziness
. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with NORVASC, ACTIVASE, ALLEGRA, DIFLUCAN, MORPHINE SULPHATE, PROTONIX, SERTRALINE. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #4995511-4
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 21, 2006. Female patient, 72 years of age, weighting 121.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, atrial flutter, blood alkaline phosphatase increased, blood urea increased, bradycardia, diarrhoea, febrile neutropenia, hypokalaemia. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS. During the same period patient was treated with NORVASC, ACTIVASE, ALLEGRA, DIFLUCAN, MORPHINE SULPHATE, PROTONIX, SERTRALINE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4897213-1
Mylotarg side effect was reported by a Health Professional from JAPAN on Jan 18, 2006. Male patient, 71 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, blood lactate dehydrogenase increased, cerebral haemorrhage, febrile neutropenia, glucose urine present, hypertension. Mylotarg dosage: 9 MG/M^2 1 X PER 1 DAY, INTRAVENOUS DRIP; SEE IMAGE. During the same period patient was treated with MERCAPTOPURINE, CYTARABINE, RANIMUSTINE, ADETPHOS. Patient died.
Mylotarg Side Effects Report #4976163-6
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Apr 03, 2006. Male patient, 71 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, blood lactate dehydrogenase increased, cerebral haemorrhage, condition aggravated, febrile neutropenia, glucose urine present, hepatic function abnormal. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, RANIMUSTINE, ADETPHOS. Patient died.
Mylotarg Side Effects Report #5052858-3
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on June 29, 2006. Male patient, 70 years of age, weighting 198.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase, bone marrow transplant
, chills, dehydration. Mylotarg dosage: 18.9 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient died on 01/08/2006.Mylotarg Side Effects Report #5056539-1
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 11, 2006. Male patient, 70 years of age, weighting 198.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, bone marrow transplant
, chills. Mylotarg dosage: 18.9 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient died on 01/08/2006.Mylotarg Side Effects Report #4952605-7
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 09, 2006. Male patient, 70 years of age, weighting 167.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, infusion related reaction, pyrexia, weight increased. Mylotarg dosage: unknown. During the same period patient was treated with CYTARABINE. Patient recovered.
Mylotarg Side Effects Report #5010738-3
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on May 12, 2006. Male patient, 70 years of age, weighting 167.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, infusion related reaction, pyrexia, weight increased. Mylotarg dosage: unknown. During the same period patient was treated with CYTARABINE. Patient recovered.
Mylotarg Side Effects Report #4744368-5
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 25, 2005. Male patient, 69 years of age, weighting 179.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, pyrexia, weight increased. Mylotarg dosage: unknown. Patient recovered.
Mylotarg Side Effects Report #4942640-7
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 28, 2006. Male patient, 69 years of age, weighting 276.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, atelectasis, blood bilirubin increased, blood creatinine increased, blood urea increased, chills, cholelithiasis, dry mouth. Mylotarg dosage: 21 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with DIPHENHYDRAMINE, ACETAMINOPHEN. Patient was hospitalized. Patient died on 05/06/2004.
Mylotarg Side Effects Report #4952627-6
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 69 years of age, weighting 179.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, angiopathy, ascites, aspartate aminotransferase increased, blood bilirubin increased, gallbladder disorder, infusion related reaction, liver disorder, liver function test abnormal. Mylotarg dosage: unknown. Patient recovered.
Mylotarg Side Effects Report #5049381-9
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on June 26, 2006. Female patient, 68 years of age, weighting 196.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, diarrhoea, hepatic enzyme increased, hypotension, hypovolaemia, renal failure acute. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with BACTRIM, CIPRO, COMPAZINE, ACYCLOVIR, FLUCONAZOLE, ALLOPURINOL, OXYCONTIN, OXYCODONE. Patient was hospitalized. Patient died on 10/08/2005.
Mylotarg Side Effects Report #5098667-0
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 24, 2006. Male patient, 68 years of age, weighting 167.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, clostridium colitis, enterococcal infection, febrile neutropenia. Mylotarg dosage: unknown. During the same period patient was treated with CYTARABINE, CANCIDAS, FLUCONAZOLE, VANCOMYCIN, CEFTAZIDIME, ALBUTEROL, VITAMINS. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4822191-0
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 21, 2005. Female patient, 68 years of age, weighting 196.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, hypotension, hypovolaemia, lung infiltration, renal failure acute, renal tubular necrosis. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENUOUS. During the same period patient was treated with BACTRIM, CIPRO, COMPAZINE, ACYCLOVIR, FLUCONAZOLE, ALLOPURINOL, OXYCONTIN, OXYCODONE. Patient was hospitalized. Patient died on 10/08/2005.
Mylotarg Side Effects Report #4836615-6
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 08, 2005. Female patient, 68 years of age, weighting 196.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, diarrhoea, hypotension, hypovolaemia, renal failure acute, renal tubular necrosis, renal vein thrombosis. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with BACTRIM, CIPRO, COMPAZINE, ACYCLOVIR, FLUCONAZOLE, ALLOPURINOL, OXYCONTIN, OXYCODONE. Patient was hospitalized. Patient died on 10/08/2005.
Mylotarg Side Effects Report #4990681-6
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 14, 2006. Female patient, 68 years of age, weighting 196.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, hepatic enzyme increased, hypotension, hypovolaemia, renal failure acute, renal tubular necrosis. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with BACTRIM, CIPRO, COMPAZINE, ACYCLOVIR, FLUCONAZOLE, ALLOPURINOL, OXYCONTIN, OXYCODONE. Patient was hospitalized. Patient died on 10/08/2005.
Mylotarg Side Effects Report #4754314-6
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 19, 2005. Female patient, 67 years of age, weighting 117.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, dyspnoea, hepatotoxicity, malignant neoplasm progression, pleural effusion. Mylotarg dosage: 9.1 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient died on 04/03/2004.
Mylotarg Side Effects Report #5119380-7
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 26, 2006. Male patient, 65 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, blood lactate dehydrogenase increased, blood urea increased, disease progression. Mylotarg dosage: 12 MG 1X PER 1 DAY, INTRAVENOUS. Patient died on 02/16/2006.
Mylotarg Side Effects Report #4867672-9
Mylotarg side effect was reported by a Physician from UNITED STATES on Apr 13, 2005. Female patient, 64 years of age, weighting 165.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, alanine aminotransferase increased, aspartate aminotransferase increased, atelectasis, blood albumin decreased, blood bilirubin increased, blood lactate dehydrogenase increased, bronchopneumonia, cardiopulmonary failure. Mylotarg dosage: 9 MG/M(2) (DOSE: 15 MG], INTRAVENOUS. During the same period patient was treated with HYDREA. Patient was hospitalized. Patient died on 06/13/1999.
Mylotarg Side Effects Report #4863969-7
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Dec 07, 2005. Male patient, 63 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acidosis, activated partial thromboplastin time prolonged, acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, disease progression, disseminated intravascular coagulation. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with METHOTREXATE. Patient died.
Mylotarg Side Effects Report #4869686-1
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Dec 20, 2005. Male patient, 63 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acidosis, acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, disseminated intravascular coagulation, febrile neutropenia, gamma-glutamyltransferase increased. Mylotarg dosage: 9 MG/M 2 1X PER 1 DAY. Patient died.
Mylotarg Side Effects Report #4947758-0
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 63 years of age, weighting 189.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, chills, hyperglycaemia, infusion related reaction. Mylotarg dosage: 13 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CYTARABINE. Patient recovered.
Mylotarg Side Effects Report #5008804-1
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on May 11, 2006. Male patient, 63 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acidosis, activated partial thromboplastin time prolonged, acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blast cell count increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with METHOTREXATE, OMEGACIN. Patient was hospitalized. Patient died.
Mylotarg Side Effects Report #4951677-3
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 62 years of age, weighting 198.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, chills, dyspnoea, infusion related reaction, pyrexia, weight increased. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. Patient recovered.
Mylotarg Side Effects Report #4720752-0
Mylotarg side effect was reported by a Physician from UNITED STATES on July 05, 2005. Male patient, 60 years of age, weighting 163.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, body temperature increased, pancytopenia, pyrexia. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with ACETAMINOPHEN, CIPRO, CARDIZEM, BENADRYL, SPORANOX, PROTONIX, ZOSYN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4947722-1
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 60 years of age, weighting 203.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, chills, febrile neutropenia, infusion related reaction, localised oedema, mental status changes, muscle spasms. Mylotarg dosage: unknown. During the same period patient was treated with NEXIUM, ALLEGRA, ALLOPURINOL, REGLAN, BENADRYL, DECADRON, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4948798-8
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 60 years of age, weighting 287.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood bilirubin increased, blood pressure increased, dialysis
, disease progression, hepatic steatosis. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with INSULIN, ACYCLOVIR, ALLOPURINOL, NORVASC, FIBRALAX, CIPROFLOXACIN, KLONOPIN. Patient was hospitalized. Patient died on 11/01/2003.Mylotarg Side Effects Report #5104158-0
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Aug 31, 2006. Male patient, 57 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blast cell count increased, blood bilirubin increased, disease progression, hepatic function abnormal, lactic acidosis, platelet count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with PRODIF, FIRSTCIN, OMEPRAZOLE, STRONG NEO MINOPHAGEN C. Patient died.
Mylotarg Side Effects Report #5191248-X
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Dec 04, 2006. Male patient, 57 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blast cells present, blood bilirubin increased, blood creatinine increased, blood urea increased, c-reactive protein increased, haematocrit decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with PRODIF, FIRSTCIN, OMEPRAL, STRONG NEO MINOPHAGEN C. Patient recovered.
Mylotarg Side Effects Report #4709019-4
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on June 21, 2005. Male patient, 57 years of age, weighting 206.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, cholecystitis, cholelithiasis, gallbladder disorder, oedema. Mylotarg dosage: 13.2 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CYTARABINE. Patient recovered.
Mylotarg Side Effects Report #4767614-0
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 30, 2005. Male patient, 57 years of age, weighting 206.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal pain upper, alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, cholecystitis, gallbladder oedema. Mylotarg dosage: 13.2 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CYTARABINE. Patient recovered.
Mylotarg Side Effects Report #5105237-4
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 29, 2006. Female patient, 56 years of age, weighting 189.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal pain
, alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood bilirubin increased, hepatic function abnormal, neutropenic sepsis. Mylotarg dosage: 10.7 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with VANCOMYCIN, LEVOFLOXACIN, ACYCLOVIR, POTASSIUM CHLORIDE, LORAZEPAM, BICARBONATE IN PLASTIC CONTAINER, CHLORIDE, FLUCONAZOLE. Patient died on 09/20/2004.